450.88
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt UTHR?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$453.28
Offen:
$450.31
24-Stunden-Volumen:
152.31K
Relative Volume:
0.21
Marktkapitalisierung:
$20.34B
Einnahmen:
$3.08B
Nettoeinkommen (Verlust:
$1.24B
KGV:
17.60
EPS:
25.6108
Netto-Cashflow:
$1.07B
1W Leistung:
+7.39%
1M Leistung:
+12.41%
6M Leistung:
+54.33%
1J Leistung:
+28.69%
United Therapeutics Corp Stock (UTHR) Company Profile
Firmenname
United Therapeutics Corp
Sektor
Telefon
(301) 608-9292
Adresse
1000 SPRING ST, SILVER SPRING, MD
Vergleichen Sie UTHR mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
UTHR
United Therapeutics Corp
|
450.90 | 20.50B | 3.08B | 1.24B | 1.07B | 25.61 |
![]()
ZTS
Zoetis Inc
|
143.64 | 64.42B | 9.39B | 2.62B | 2.22B | 5.8121 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
14.54 | 45.95B | 29.96B | 957.25M | 4.77B | 0.2956 |
![]()
HLN
Haleon Plc Adr
|
8.88 | 39.14B | 14.26B | 1.98B | 2.47B | 0.4327 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.27 | 22.90B | 16.70B | -157.13M | 1.19B | -0.1446 |
United Therapeutics Corp Stock (UTHR) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-09-26 | Eingeleitet | RBC Capital Mkts | Outperform |
2025-06-02 | Eingeleitet | Cantor Fitzgerald | Overweight |
2025-04-25 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
2025-04-21 | Hochstufung | BofA Securities | Underperform → Neutral |
2024-07-11 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2024-02-12 | Hochstufung | Goldman | Sell → Neutral |
2024-02-05 | Eingeleitet | Leerink Partners | Outperform |
2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
2022-12-06 | Eingeleitet | UBS | Buy |
2022-12-05 | Eingeleitet | Goldman | Sell |
2022-10-11 | Eingeleitet | Morgan Stanley | Overweight |
2022-09-20 | Bestätigt | BofA Securities | Underperform |
2022-09-19 | Fortgesetzt | Wedbush | Outperform |
2022-02-11 | Eingeleitet | BTIG Research | Neutral |
2021-07-14 | Hochstufung | Argus | Hold → Buy |
2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
2021-02-01 | Hochstufung | H.C. Wainwright | Neutral → Buy |
2020-09-14 | Fortgesetzt | JP Morgan | Overweight |
2020-06-25 | Bestätigt | H.C. Wainwright | Neutral |
2020-03-10 | Hochstufung | Jefferies | Hold → Buy |
2020-02-27 | Hochstufung | Cowen | Market Perform → Outperform |
2020-01-31 | Hochstufung | JP Morgan | Neutral → Overweight |
2019-12-03 | Eingeleitet | BofA/Merrill | Underperform |
2019-08-01 | Hochstufung | Jefferies | Underperform → Hold |
2019-08-01 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
2019-07-01 | Hochstufung | Credit Suisse | Neutral → Outperform |
2019-05-17 | Hochstufung | UBS | Sell → Neutral |
2019-05-09 | Hochstufung | Credit Suisse | Underperform → Neutral |
2018-10-12 | Hochstufung | Standpoint Research | Hold → Buy |
2018-08-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
2018-04-03 | Hochstufung | Credit Suisse | Underperform → Neutral |
2018-02-22 | Bestätigt | Barclays | Underweight |
2018-01-18 | Fortgesetzt | Credit Suisse | Underperform |
2017-12-27 | Bestätigt | Wedbush | Outperform |
2017-04-27 | Bestätigt | Wedbush | Outperform |
2017-03-30 | Eingeleitet | UBS | Sell |
2017-03-16 | Eingeleitet | Credit Suisse | Underperform |
Alle ansehen
United Therapeutics Corp Aktie (UTHR) Neueste Nachrichten
Is There Still an Opportunity in United Therapeutics After Its 25.8% Year to Date Surge? - simplywall.st
How Positive TETON-2 Results for Tyvaso Have Changed United Therapeutics' (UTHR) Investment Story - simplywall.st
News impact scoring models applied to United Therapeutics CorporationPortfolio Growth Summary & Weekly Top Gainers Alerts - newser.com
United Therapeutics stock hits all-time high at 442.02 USD - Investing.com
United Therapeutics stock hits all-time high at 442.02 USD By Investing.com - Investing.com South Africa
TD Cowen maintains Buy rating on United Therapeutics stock, citing IPF opportunity - Investing.com
Jefferies reiterates Buy rating on United Therapeutics stock amid patent case - Investing.com
UBS maintains United Therapeutics stock Buy rating amid patent litigation By Investing.com - Investing.com Canada
United Therapeutics COO sells $9.49m in UTHR stock By Investing.com - Investing.com South Africa
United Therapeutics COO sells $9.49m in UTHR stock - Investing.com India
Is IPF the Next Big Market Opportunity for United Therapeutics? - Yahoo Finance
UBS maintains United Therapeutics stock Buy rating amid patent litigation - Investing.com India
United Therapeutics president Michael Benkowitz sells shares worth $3.65m - MSN
United Therapeutics stock price target raised to $580 by UBS on Tyvaso outlook - Investing.com Australia
United Therapeutics Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
United Therapeutics stock maintains Buy rating at H.C. Wainwright amid patent case developments - Investing.com Australia
United Therapeutics (UTHR): UBS Raises Price Target to $580, Mai - GuruFocus
United Therapeutics stock maintains Buy rating at H.C. Wainwright amid patent case developments By Investing.com - Investing.com Australia
Will United Therapeutics Corporation (UTH) stock beat international competitionWeekly Trade Review & Reliable Trade Execution Plans - newser.com
United Therapeutics stock holds Buy rating at TD Cowen on strong IPF data - Investing.com Canada
United Therapeutics stock holds Buy rating at TD Cowen on strong IPF data By Investing.com - Investing.com South Africa
United Therapeutics Corporation $UTHR Holdings Lifted by State of Alaska Department of Revenue - MarketBeat
Why United Therapeutics Corporation (UTH) stock stays undervaluedTrade Ideas & Verified Chart Pattern Trade Signals - newser.com
Analyzing drawdowns of United Therapeutics Corporation with statistical tools2025 Market WrapUp & Free Risk Controlled Daily Trade Plans - newser.com
Why United Therapeutics Corporation (UTH) stock gets analyst attention2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
Chart based analysis of United Therapeutics Corporation trendsInsider Selling & Real-Time Stock Movement Alerts - newser.com
Augustine Asset Management Inc. Makes New Investment in United Therapeutics Corporation $UTHR - MarketBeat
Analysts Offer Insights on Healthcare Companies: United Therapeutics (UTHR) and Zai Lab (ZLAB) - The Globe and Mail
United Therapeutics Rides Tyvaso Wins To Major Gains - Finimize
RBC Capital initiates United Therapeutics stock with Outperform rating By Investing.com - Investing.com Canada
RBC Capital Initiates Coverage on United Therapeutics (UTHR) wit - GuruFocus
This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Benzinga
Sowell Financial Services LLC Invests $333,000 in United Therapeutics Corporation $UTHR - MarketBeat
RBC Capital initiates United Therapeutics stock with Outperform rating - Investing.com
Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat
Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock By Investing.com - Investing.com Nigeria
Insider Sell: Christopher Causey Sells 1,000 Shares of United Th - GuruFocus
Rothblatt, United Therapeutics CEO, sells $3.4m in UTHR stock - Investing.com India
United Therapeutics Corp. Hits New 52-Week High of $442.01 - Markets Mojo
United Therapeutics Corporation $UTHR Shares Sold by Ruffer LLP - MarketBeat
Finanzdaten der United Therapeutics Corp-Aktie (UTHR)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):